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Abstract
Background: Subjective cognitive decline (SCD), i.e., the self-perceived feeling of worsening cognitive function,
may be the first notable syndrome of preclinical Alzheimer’s disease and other dementias. However, not all
individuals with SCD progress. Stability of SCD, i.e., repeated reports of SCD, could contribute to identify individuals
at risk, as stable SCD may more likely reflect the continuous neurodegenerative process of Alzheimer’s and other
dementias.
Methods: Cox regression analyses were used to assess the association between stability of SCD and progression to
MCI and dementia in data derived from the population-based Leipzig Longitudinal Study of the Aged (LEILA75+).
Results: Of 453 cognitively unimpaired individuals with a mean age of 80.5 years (SD = 4.2), 139 (30.7 %) reported
SCD at baseline. Over the study period (M = 4.8 years, SD = 2.2), 84 (18.5 %) individuals had stable SCD, 195 (43.1 %)
unstable SCD and 174 (38.4 %) never reported SCD. Stable SCD was associated with increased risk of progression
to MCI and dementia (unadjusted HR = 1.8, 95 % CI = 1.2–2.6; p < .01), whereas unstable SCD yielded a decreased
progression risk (unadjusted HR = 0.5, 95 % CI = 0.4–0.7; p < .001) compared to no SCD. When adjusted for baseline
cognitive functioning, progression risk in individuals with stable SCD was significantly increased in comparison to
individuals with unstable SCD, but not compared to individuals without SCD.
Conclusions: Our results, though preliminary, suggest that stable SCD, i.e., repeated reports of SCD, may yield an
increased risk of progression to MCI and dementia compared to unstable SCD. Baseline cognitive scores, though
within a normal range, seem to be a driver of progression in stable SCD. Future research is warranted to investigate
whether stability could hold as a SCD research feature.
Keywords: Subjective cognitive decline, Mild cognitive impairment, Dementia, Alzheimer’s disease, Progression risk,
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Background
Individuals with subjective cognitive decline (SCD), i.e.,
a self-perceived feeling of worsening cognitive function
that is not objectifiable from neuropsychological testing,
may have an increased risk to develop mild cognitive
impairment (MCI) and dementia [1, 2]. In fact, SCD may
be the first notable syndrome of preclinical Alzheimer’s dis-
ease (AD) and other dementias [3]. In studies with more
than four years observation time, it was 26.6 % of those
with SCD who developed MCI, and 14.1 % who developed
dementia, as a meta-analysis revealed [1]. This cumulated
in a doubled risk of dementia compared to cognitively un-
impaired elderly without SCD. Thus, SCD could hold value
for the early detection of future cognitive decline and,
subsequently, as a starting point for early prevention and
intervention trials. This would be particularly interesting
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as at the SCD stage, global cognitive functioning may be
well preserved.
However, the prognosis from SCD is unclear precisely
because not all individuals with SCD progress to MCI or
dementia. In fact, SCD is a frequent syndrome prevalent
in 25 to 50 % of the elderly [4], and besides being a risk
factor for MCI and dementia, SCD could also be a) a
functional manifestation of various underlying causes
(e.g., depression, medication, personality traits) [3, 5], or
b) a distorted awareness of normal performance as im-
paired [6]. Consequently, it would be useful to be able to
better differentiate between individuals with SCD who
progress to MCI and dementia from individuals with
SCD who do not progress.
One such approach may lay in the investigation of the
stability of SCD. Previous studies on MCI and dementia
progression usually relied on a single measurement point
of SCD leaving stability unaddressed [1, 2]. Moreover,
due to the varying possible underlying causes, such sub-
jectively perceived cognitive impairment in general is
considered a quite unstable syndrome, and it can revert
to a subjectively unimpaired experience of cognitive
functioning instead of progressing to MCI or dementia
[7, 8]. Reisberg et al. [9] stated, there is a need to clarify
whether “SCD inexorably progresses into MCI and ul-
timately AD”, or whether “it is inherently less stable,
varying with yet undermined factors (microvascular dis-
ease and/or mood)”.
The typical course of late onset Alzheimer’s disease
(AD), the most frequent type of dementia, is marked by
a long continuous process of pathological brain changes
which evolve years before diagnosis [10, 11]. If SCD oc-
curs due to preclinical AD, we could assume that SCD
might be experienced rather constantly over time, hence,
being a more stable syndrome that is reported repeatedly –
as opposed to SCD due to other underlying causes that
might lead to a more unstable experience of SCD, e.g.,
due to mood.
Aims of the study
We aimed to longitudinally investigate multiple time
points of SCD and its stability in regard to progression
to MCI and dementia in a population-based sample of
cognitively unimpaired elderly (≥75 years) who were
followed over 8 years in total.
Methods
Study design and sample
Data were derived from the Leipzig Longitudinal Study
of the Aged (LEILA75+), a population-based study on
the epidemiology of dementia and MCI. Initially, a total
of 1692 individuals aged at least 75 years residing in the
Leipzig-South district were selected for participation. Of
these, 1500 individuals were identified by systematic
random sampling from an age-ordered list from the
local registry office. In addition, 162 institutionalized
individuals were included by systematic random sam-
pling from an age-ordered list by the four institutions
in the study area. Study details have been published
elsewhere [12].
Of the 1692 invited individuals, 242 (14.2 %) refused,
57 (3.4 %) had died, 15 (0.9 %) were not traceable, and
113 (6.7 %) were shielded by relatives. Finally, the
LEILA75+ cohort comprised 1265 (74.8 %) individuals.
Non-participants did not differ from participants regard-
ing age (U= 263553, p = .46), gender (χ2 = 0.40, p = .53),
or marital status (χ2 = 5.03, p = .17).
Data collection
Data were collected over a total observation period of
eight years between January 1997 (begin of baseline) and
April 2005 (end of follow-up 5). Follow-up assessments
took place on average every 1.4 years. Structured clinical
interviews at baseline and follow-up were conducted at
participants’ homes by trained psychologists and physi-
cians. In addition, structured interviews were held with
proxies.
Assessment instruments and procedures
The main assessment instrument was the Structured
Interview for the Diagnosis of Dementia of Alzheimer
type, Multi-infarct Dementia and Dementia of other
Aetiology according to DSM-III-R, DSM-IV, and ICD-10
(SIDAM) [13]. The SIDAM comprises a neuropsycho-
logical test and a section for clinical judgment and third-
party information on psychosocial impairment, including
a 14-item scale to assess activities of daily living
(SIDAM-ADL Scale). The SIDAM neuropsychological
test consists of 55 items, including all 30 items of the
Mini-Mental State Examination (MMSE) [14]. Six areas
of neuropsychological functioning are covered: 1) orien-
tation (time and place); 2) memory (delayed verbal re-
call, delayed visual reproduction, questions on
biography and history); 3) intellectual abilities (abstract
thinking) and judgment (plausibility judgments, describ-
ing pictures representing actions); 4) verbal and calcula-
tion abilities (calculating serial sevens, spelling
backward, backward digit span); 5) visual-spatial con-
structional abilities (copying figures); and 6) aphasia and
apraxia (naming objects, reading and obeying a sentence,
writing a sentence, and performing a three-stage
command).
If it was not possible to administer the SIDAM, a
structured proxy interview was offered including the
Clinical Dementia Rating scale (CDR) [15].
SCD was evaluated prior to cognitive testing by ask-
ing the participant: “Do you have problems with your
memory?”.
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We identified depressive symptoms using the German
version of the 20-item Center of Epidemiologic Studies
Depression Scale (CES-D) [16].
A standardized interview provided information on
sociodemographic characteristics.
Death dates were obtained from relatives or the registry
office.
Definition of cases
SCD
SCD was assumed if participants were cognitively unim-
paired and stated to have memory problems unrelated to
an event or condition explaining the memory problems
according to recent research criteria [3]. Consequently,
we excluded participants who met the following criteria:
1) a diagnosis of MCI or dementia, 2) a MMSE score
below 26 points, 3) presence of a major psychiatric (e.g.,
major depression, anxiety), neurological (e.g., Morbus
Parkinson) or medical condition (e.g., stroke) that could
affect cognitive functioning.
We then built two subgroups of SCD: stable vs. un-
stable SCD. Stable SCD was assumed if SCD was con-
sistently reported at every assessment until progression
to MCI or dementia or, in case of non-progression, the
last completed follow-up. By contrast, unstable SCD was
assumed if SCD was not consistently reported at every
assessment, but occasionally, until progression to MCI
and dementia or, in case of non-progression, the last
completed follow-up.
Controls
Individuals who never reported SCD at baseline and
follow-up until progression to MCI or dementia or last
completed follow-up without progression were considered
controls (CON).
MCI
Diagnosis of MCI was based on Winblad criteria [17].
They comprised absence of dementia, at most minimal
impairment in instrumental activities of daily living, and
evidence of cognitive decline in objective cognitive tests
at least one standard deviation below age- and education
specific norms [18] on one or more main domain of
cognitive functioning as assessed by the SIDAM. We
refrained from the criterion of the presence of a memory
complaint to be able to consider any case of cognitive
impairment in differentiation to CON and SCD [19].
Dementia
Dementia status at any assessment was agreed at con-
sensus conferences with physicians and psychologists
according to DSM-IV criteria [20]. The diagnosis was
based on SIDAM results or, if proxy interviews only, on
CDR data.
Outcome
We dichotomously defined the outcome variable in pro-
gression (to MCI or dementia) and non-progression.
Progression was assigned if participants were first-time
diagnosed with incident MCI or dementia at follow-up.
Non-progression was assumed if individuals had remained
CON or SCD at every completed follow-up.
Statistical analysis
Group differences in socio-demographic and health char-
acteristics at baseline between individuals with stable vs.
unstable patterns of SCD and CON were analyzed ap-
plying Kruskal-Wallis-tests for continuous variables and
χ2 tests for categorical variables.
We developed univariate (model 1) and multivariate
Cox proportional hazards models (models 2–4) to assess
the association of progression to MCI and dementia in
stable vs. unstable patterns of SCD in reference to CON.
Multivariate Cox models were stepwise adjusted for
age, gender, education (categorized into low, middle and
high according to the CASMIN criteria [21], categorical)
(model 2), depressive symptoms (continuous, CES-D) [16])
(model 3), and cognitive functioning (continuous, MMSE
[14]) (model 4).
Kaplan-Meier survival analyses were applied to deter-
mine time to progression in regard to SCD stability. Time
to progression was defined as the interval from baseline to
first follow-up of progression to MCI or dementia or, in
case of non-progression, date of last completed follow-up.
Individuals without progression by follow-up 5 were
treated as censored data. A Log-rank test was performed
to assess the unadjusted difference in time to progression
between individuals with stable vs. unstable patterns of
SCD vs. CON. Furthermore, a stratified Cox regression-
based test for equality of survival was performed adjusted
for age, gender, and education.
For all analyses a significance level of α = 0.05 was
applied. We used Stata/SE, version 13.0 (StataCorp LP,
College Station, Texas/USA).
Results
Participants
Of the 1265 LEILA75+ participants at baseline, 812
(64.2 %) individuals were excluded, primarily because
of dementia (n = 220; 17.4 %), MCI (n = 327; 25.8 %),
MMSE < 26 points (n = 73; 5.8 %), incomplete cognitive
assessment (n = 32; 2.5 %), major depression according
to DSM-IV criteria (n = 7; 0.6 %), stroke (n = 34; 2.7 %),
other major psychiatric diseases (n = 5; 0.4 %), substance
abuse (n = 5; 0.4 %), and not completing at least one
follow-up (n = 109; 8.6 %) (Fig. 1). The final analysis pool
comprised 453 (35.8 %) individuals.
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Characteristics of the study sample
Among the 453 study participants, 139 (30.7 %) individ-
uals reported SCD at baseline. Over the study period, 84
(18.5 %) had stable SCD, 195 (43.0 %) had unstable SCD
and 174 (38.4 %) never reported SCD (CON). Individuals
with stable patterns reported SCD at 3 consecutive assess-
ments (every 1.4 years) on average (M = 2.7; SD = 1.4). In
those individuals with unstable SCD, reporting of SCD
and no SCD switched twice on average (M = 1.7; SD = 0.8)
between assessments. Individuals in the CON group never
reported SCD overM = 3.1 (SD = 1.8) assessments.
The mean age of the participants was 80.5 years
(SD = 4.2), of them 328 (72.7 %) were women. Individuals
with stable SCD were significantly older, had slightly lower
MMSE scores, and higher depressive symptoms than indi-
viduals with unstable SCD and CON (Table 1). There were
no group differences regarding gender and education.
The total follow-up time was 8 years, the mean follow-
up time cumulated in 4.8 years (SD = 2.2). Almost half of
all participants (n = 218; 48.1 %) completed all assess-
ments waves. Of 235 (51.9 %) individuals who were lost
to follow-up, 122 (26.9 %) had deceased, 94 (20.7 %) re-
fused further participation, and in 19 (4.2 %) contacting
failed or they were lost for other reasons.
Individuals who were lost to follow-up were significantly
older (M = 81.4, SD = 4.5 vs. M = 79.5, SD = 3.7; p < .001),
more frequently male (χ2(1, 453) = 4.56, p < .05) and had
lower MMSE scores (M = 28.0, SD = 1.3 vs. M = 28.3;
SD = 1.2, p < .01), but did not differ in regard to education
(χ2(2, 453) = 3.20; p = .20).
Stability of SCD and progression risk
During an average observation of M = 4.8 years (SD = 2.2),
49 (28.2 %) of 174 CON, 39 (20 %) out of 195 individuals
with unstable SCD, and 36 (42.9 %) out of 84 individuals
with stable SCD incidentally developed either MCI or
dementia (χ2(2, 453) = 16.49, p < .01). Unadjusted Cox
regression revealed a significantly increased hazard ra-
tio (HR) of 1.8 for progression to MCI and dementia in
individuals with stable SCD in reference to CON (95 %
confidence intervaI/CI = 1.2–2.6; p < .01) (Table 2). This
association remained significant in the multivariate Cox
model adjusted for age, gender, education (HR = 1.8,
95 % CI = 1.2–2.6; p < .05) and depressive symptoms
(HR = 1.6, 95 % CI = 1.0–2.3; p < .05). However, when
additionally controlled for cognitive functioning, HR of
progression to MCI and dementia in individuals with
stable SCD reduced to 1.4 (95 %-CI = 0.9–2.1) in reference
to CON, which was not significant anymore (p = .13).
Unstable SCD, by contrast, yielded a significantly lower
risk of progression in the univariate as well as in all
multivariate Cox models in reference to CON (Table 2).
Fig. 1 Sample and sample attrition
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Furthermore, Wald tests to contrast between the stable
and unstable SCD group indicated a significant difference
in the progression risk in all four models (model 1: χ2 =
38.22, p < .001; model 2: χ2 = 32.94; p < .001; model 3:
χ2 = 30.27, p < .001; model 4: χ2 = 28.67, p < .001).
Stability of SCD and time to progression
The overall time to progression cumulated in 7.2 (95 %
CI = 7.0–7.3) years in median as estimated by the Kaplan
Meier Method (Table 3). Time to progression was signifi-
cantly shorter in stable SCD (Median = 6.2 years, 95 % CI =
4.6–7.7) compared to unstable SCD (Median = 7.4, 95 %
CI = 7.2–7.6) and CON (Median = 7.2, 95 % CI = 6.8–7.6;
p < .001) (Fig. 2). When adjusted for age, gender and
education, the difference in time to progression remained
significant as estimated with a stratified Cox regression-
based test for equality of survival (χ2(2, 453) = 4.97, p < .05).
Discussion
We aimed to investigate stable vs. unstable patterns of
subjective cognitive decline (SCD) in regard to progres-
sion to mild cognitive impairment (MCI) and dementia
in a population-based sample of cognitively unimpaired
elderly. Stable SCD, i.e., repeated reports of SCD, yielded
an increased risk of progression to MCI and dementia
compared to unstable SCD over an average observation
period of 4.8 years.
Risk of progression seemed to be driven in part by
baseline cognitive functioning in the stable SCD group,
but not in the unstable SCD group.
Table 2 Unadjusted and adjusted hazard ratios (HR) of progression to mild cognitive impairment (MCI) and dementia by stable vs.
unstable subjective cognitive decline (SCD) in reference to controls (no SCD)
Model 1 Model 2 Model 3 Model 4
HR (95 %-CI) p HR (95 %-CI) p HR (95 %-CI) p HR (95 %-CI) p
SCD Reference: no SCD 1 1 1 1
Unstable SCD 0.53 (0.37–0.74) <.001 0.56 (0.39–0.79) <.01 .50 (0.35–0.72) <.001 0.47 (0.33–0.69) <.001
Stable SCD 1.78 (1.24–2.55) <.01 1.76 (1.20–2.58) <.05 1.55 (1.04–2.32) < .05 1.38 (0.91–2.09) .13
Age – 1.01 (1.01–1.02) <.001 1.01 (1.01–1.02) < .001 1.01 (1.00–1.02) <.01
Gender Reference: male – 0.95 (0.67–1.34) .76 0.96 (0.68–1.36) .83 0.94 (0.67–1.34) .75
Education Reference: low – 1 1 1
Middle 1.72 (1.21–2.44) <.01 1.57 (1.09–2.27) <.05 1.61 (1.11–2.33) <.05
High 1.36 (0.88–2.10) .17 1.34 (0.85–2.11) .20 1.54 (0.96–2.47) .07
Depressive symptoms/CES-D – – 1.00 (1.00–1.01) .05 1.00 (1.00–1.01) .09
Cognitive functioning/MMSE – – – 0.97 (0.94–0.99) <.05
Abbreviations: CES-D 20-item Center of Epidemiologic Studies Depression Scale, CI confidence interval, HR hazard ratio, MCI mild cognitive impairment,
MMSE Mini-Mental State Examination, SCD subjective cognitive decline
Table 1 Characteristics of the study sample at baseline (n = 453)
Variablesa Total (n = 453) Stable SCD (n = 84) Unstable SCD (n = 195) CON (n = 174) P Value (group difference)b
Age, mean (SD) 80.49 (4.21) 81.65 (4.49) 80.20 (4.07) 80.01 (4.06) <.05
Gender, n (%)
Male 125 (27.6) 24 (28.6) 58 (29.7) 43 (24.7)
Female 328 (72.7) 60 (71.4) 137 (70.3) 131 (75.3) .55
Education, n (%)
Low 306 (67.7) 59 (71.1) 140 (71.8) 107 (61.5)
Middle 92 (20.4) 13 (15.7) 35 (17.9) 44 (25.3)
High 54 (11.9) 11 (13.3) 20 (10.3) 23 (13.2) .20
Cognitive functioning/MMSE, mean (SD) 28.14 (1.27) 27.76 (1.19) 28.19 (1.31) 28.27 (1.23) <.01
Depressive symptoms/CES-D, mean (SD) 13.55 (7.25) 16.47 (7.17) 13.64 (6.99) 12.07 (7.20) <.001
Follow-up time, years, mean (SD) 4.83 (2.22) 4.01 (2.11) 5.61 (1.90) 4.37 (2.32) <.001
Abbreviations: CES-D 20-item Center of Epidemiologic Studies Depression Scale, CON controls/individuals without SCD, MMSE Mini-Mental State Examination,
SCD subjective cognitive decline
aMissing values, n(%): education = 1 (0.2 %); depressive symptoms: 28 (6.2 %); group statistic based on Kruskal-Wallis-tests for continuous variables and χ2 tests
categorical variables
bStable SCD vs. unstable SCD vs. CON
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There is a lack of studies that investigated stability of
SCD in relation to MCI and dementia progression. One
study, based on a memory clinic sample of 230 cogni-
tively normal individuals with SCD over 50 years of age,
distinguished three outcomes after eight years, namely
non-decline, decline and diagnostically unstable (i.e., a
change of diagnosis over time from normal to MCI, then
back to normal) [22]. The authors concluded that the
presence of SCD was a predictor of future cognitive de-
cline, but it also increased the likelihood of an unstable
diagnosis. Such an unstable diagnosis was associated with
affective symptoms, particularly anxiety. The authors
noted that the associations found in previous studies on
cognitive decline and affective symptoms might be ex-
plained at least in part by including individuals with an
unstable diagnosis who might later revert to normal.
Besides, the possibility of reversion to “normal”, i.e., the
perception of sufficient memory function with no more
experience of SCD, seems much neglected in research
as the reversion to normal cognition in MCI [23]. This
may suggest, in line with our results, that it might be
useful to distinguish between stable and unstable – in-
cluding reversing – courses of SCD as they might relate
to different aetiologies.
That stable SCD might be associated with an increased
progression risk to MCI and dementia makes sense in
the view of the fact that AD, the most frequent type of
dementia, is characterized by a long continuous process
of slow neurodegeneration into marked cognitive decline
at advanced stages. It seems reasonable to assume that
SCD, if a syndrome of preclinical AD, should be con-
stantly experienced over a longer time period in this on-
going process rather than occasionally. Interestingly, this
is underlined by our result that an unstable pattern of
SCD, by contrast, was not predictive of MCI and demen-
tia. In fact, individuals who did not consistently but only
occasionally report SCD throughout the assessments dis-
played a decreased risk of MCI and dementia compared
to individuals with stable SCD and those who never re-
ported SCD. Potentially, this might be explained by tem-
porary clinical conditions out of which SCD might result,
e.g., due to a depressive episode, pain, fatigue, medications,
or distressing life events [24]. As soon as such temporary
conditions resolve, cognitive functioning may not be
experienced as impaired anymore.
Otherwise, it has been reported previously that indi-
viduals in general struggle with differentiating between a
normal and a pathological process of ageing [6] which
could also be a reason for inconsistent reports of SCD.
From a functional perspective, occasional reports of SCD
might also be explained as a “distorted awareness of a
present cognitive state compared to a past one” resulting in
complaints of inexistent cognitive decline [6]. Individuals
may over-estimate subtle changes in cognitive functioning
that may only reflect age-related normative cognitive de-
cline without becoming overt dementia later [25]. Over-
estimation of cognitive changes could be driven by a fear of
anticipatory dementia [26]. Such a fear is also associated
with symptom-seeking for the disease [27].
By contrast, if SCD is completely absent, it could re-
flect either that there are indeed no memory problems
or it could indicate poor awareness, i.e., the inability to
accurately appraise aspects of cognitive functioning, also
referred to as anosognosia [25]. If some of the individ-
uals who did not express SCD had a poor awareness of
cognitive changes, and thus, failed to express SCD, then
this could explain why individuals who never reported
Table 3 Outcomes over the study perioda in individuals with stable vs. unstable patterns of subjective cognitive decline (SCD) and
controls (CON)b
Total (n = 453) Stable SCD (n = 84) Unstable SCD (n = 195) CON (n = 174) P Value (group
difference)
No cognitive decline, n (%) 329 (59.4) 48 (57.1) 156 (80.0) 125 (71.8)
Mild cognitive impairment (MCI), n (%) 69 (15.2) 21 (25.0) 19 (9.7) 29 (16.7)
Dementia, n (%) 55 (12.1) 15 (17.9) 20 (10.3) 20 (11.5) <.01
Time to cognitive decline, median (95 %-CI) 7.15 (7.01–7.29) 6.15 (4.59–7.70) 7.35 (7.15–7.55) 7.18 (6.79–7.56) <.001
atotal observation time: 8 years, mean observation time: 4.8 years (SD = 2.2)
bindividuals without objective cognitive impairment and without SCD
Fig. 2 Kaplan-Meier cumulative probability of progression to mild
cognitive impairment or dementia in stable vs. unstable subjective
cognitive decline (SCD) vs. controls
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SCD had an intermediate level of progression risk be-
tween the stable and unstable SCD group in our study.
As there is evidence for variability in the level of aware-
ness in MCI, it is likely to assume different levels of
awareness in SCD where changes in cognitive functioning
may be more subtle and, therefore, may be even more dif-
ficult to evaluate accurately [28]. However, whether differ-
ences in awareness are associated with progression risk to
MCI and dementia is not known [25, 28].
As hypothesized, individuals with stable SCD exhibited
the highest progression risk to MCI and dementia com-
pared to individuals with unstable SCD and no SCD.
When adjusted for cognitive functioning (MMSE scores),
however, progression risk in individuals with stable SCD
was only significantly increased in comparison to indi-
viduals with unstable SCD, but not compared to individ-
uals without SCD. We assume, that the averagely slightly
lower MMSE scores in individuals with stable SCD
could rather reflect early pre-clinical cognitive decline as
opposed to in individuals with unstable SCD. It has been
previously reported, e.g., by St John and Montgomery [29],
that individuals with SCD (regardless of its stability) ex-
perience “real” cognitive losses, “which is also apparent as
lower [cognitive] scores”. Reisberg et al. [9] added that a
lower MMSE score in individuals with SCD is not simply
statistically significant, but it may be “real” in that individ-
uals with SCD experience pre-clinical cognitive losses.
Our results additionally suggest that this may particularly
apply to individuals who have a stable experience of SCD
as opposed to an unstable experience of SCD.
As the need for a refinement of the research criteria of
SCD has been pointed out [3, 7], our preliminary results
suggest that stability of SCD might be a feature that
could contribute to better identify individuals at risk for
MCI and dementia.
Besides, it has been reported previously that SCD pre-
dicts a shorter time to progression compared to individ-
uals without SCD [9, 30]. In our study, it was particularly
stable SCD that was associated with a significantly shorter
time to progression (median: 6.2 years). By contrast,
unstable SCD revealed even a slightly longer progression-
free survival time (median: 7.4 years) than controls
(median: 7.2 years). However, we cannot exclude that
individuals with stable SCD might potentially be more
advanced in the pre-clinical phase of cognitive deterior-
ation, thus, having a shorter time until MCI or demen-
tia become overt. SCD might be experienced stable
only after some subtle cognitive changes have occurred,
perhaps allowing the chance to experience unstable
SCD before such changes.
We have to consider some limitations. First, SCD was
only measured by asking a simple question concerning
memory problems. Even though the question “Do you have
problems with your memory?” may be a valid measure for
global memory functioning [31], there is a lack of psycho-
metric data concerning its longitudinal use. Future investi-
gations of the stability of SCD with more comprehensive
assessments (e.g., assessing other domains but memory or
asking for related worries) could shed more light on the
potential link to MCI and dementia progression risk.
Second, current research criteria on SCD [3] also in-
clude biomarker abnormalities consistent with the AD
pathology. In our study, we were not able to evaluate
biomarkers in relation to patterns of SCD progression –
future studies in this regard might be useful. Third, we
otherwise applied those SCD research criteria which
lead to the exclusion of a substantial proportion of the
LEILA75+ participants. It is questionable whether such
strict criteria that exclude major psychiatric, neurological
or medical disorders reflect the actual at risk population
for progression to MCI and dementia, especially as older
adults can often simultaneously have such comorbidity.
Finally, the exclusion of such a substantial part of
the cohort may also limit the generalizability of our
results, even though the LEILA75+ study does have a
population-based design. On the other hand, to the best of
our knowledge, we are the first to present results on SCD
patterns in community-dwelling elders.
Conclusion
Our present results, though preliminary, suggest an in-
creased risk of progression to MCI and dementia in in-
dividuals with stable SCD, i.e., consistent repeated SCD
reports, compared to unstable SCD. Baseline cognitive
scores, though within a normal range, seem to be a
driver of progression in stable SCD. This may have im-
plications for both research and clinical practice. In
clinical practice, special attention should be put on re-
peated reports of SCD. Concerning research, further
studies would be useful to establish whether stability,
e.g., in form of a time criterion, could hold as an add-
itional SCD research feature.
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